01.08.2010 | Commentary | Ausgabe 4/2010
The interpretation of brain natriuretic peptide in critical care patients; will it ever be useful?
- Zeitschrift:
- Critical Care > Ausgabe 4/2010
Wichtige Hinweise
Competing interests
The authors declare that they have no competing interests.
Abstract
The measurement of B-type natriuretic peptide (BNP) is recommended for the diagnosis of decompensated heart failure, the prognosis of chronic heart failure is worse if BNP is increased and studies suggest that BNP is useful to guide therapy. A study by Di Somma and colleagues adds to the body of evidence showing that patients with a marked decrease in BNP concentrations during their hospital admission are less likely to be readmitted with a further adverse cardiac event than patients in whom BNP fails to decrease. However, the wider interpretation of BNP concentrations in critically ill patients with other conditions remains uncertain.
